Craig-Hallum Maintains Buy on Fennec Pharmaceuticals, Lowers Price Target to $17
Craig-Hallum Maintains Buy on Fennec Pharmaceuticals, Lowers Price Target to $17
Craig-Hallum维持对Fennec制药的买入,将目标股价下调至17美元
Craig-Hallum analyst Chase Knickerbocker maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and lowers the price target from $20 to $17.
Craig-Hallum分析师Chase Knickerbocker维持Fennec Pharmicals(纳斯达克股票代码:FENC)的买入并将目标股价从20美元下调至17美元。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。